Heritage Valley Health System, which fell victim to a worldwide cyberattack last week, says that all acute-, ambulatory- and ancillary-care services have been restored at its medical campuses and satellite community locations.
Drugmakers Baxter International and Claris Injectables agreed to divest two pharmaceutical products to settle Federal Trade Commission antitrust concerns over Baxter's proposed $625 million acquisition of Claris' injectable drugs business.
The House of Representatives passed bipartisan legislation Wednesday that reauthorizes the FDA's ability to collect user fees from drug and device makers, as policymakers look to avoid thousands of layoffs if the current agreement expires.
Blood transfusions have been a long-standing practice at health systems, despite known complications, and are believed to improve patient outcomes. A new study finds the costs and potential risks associated with the procedures outweigh the benefits.
Following a disappointing first quarter, Athenahealth reported that its operating income back in the black in the second quarter, with a 15% uptick in revenue.